Physician profile
Daniel Solano
NPI 1912367541
$1,205.02
in general payments reported to CMS, 2019-2025
15 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.53 · 2021: $161 · 2022: $41.85 · 2023: $172 · 2024: $378 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923 · Gift: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.19 |
| Gift | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $247.66 | 2025 | Xdemvy |
| Alcon Vision LLC | $241.32 | 2021-2025 | Clareon, Rocklatan, Centurion |
| Horizon Therapeutics Plc | $164.65 | 2021-2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $124.91 | 2021-2024 | Tecnis Iol |
| Dompe US, INC. | $87.58 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $70.62 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $46.72 | 2021-2025 | Acthar |
| Astellas Pharma US INC | $46.09 | 2024 | Izervay |
| Bausch & Lomb Americas INC. | $42.68 | 2024-2025 | Miebo, Xiidra, Envista Envy Iol |
| Abbvie INC. | $26.52 | 2022 | |
| Haag-Streit USA, INC. | $25.00 | 2025 | |
| Sun Pharmaceutical Industries INC. | $24.77 | 2021 | |
| Harrow Eye, LLC | $19.50 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| New World Medical,INC. | $17.60 | 2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Solano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.